InnoTherapy

InnoTherapy, Inc. is a medical device company based in Seoul, South Korea, specializing in the development of hemostatic adhesives designed for use in various surgical environments and bleeding situations. Founded in 2010, the company utilizes bio-inspired technology to create innovative medical materials that mimic the adhesive properties found in nature. Its product lineup includes Hemoleast, InnoSEAL, and EndoSil, each tailored for specific applications such as surgical procedures, mucous membranes, and laparoscopic surgery. Additional offerings feature a surgical hemostatic pad that transforms into a gel on contact with blood and other specialized agents that can successfully manage bleeding in challenging scenarios. InnoTherapy focuses on advancing medical solutions that enhance surgical outcomes and patient care.

1 past transactions

H2U

Series B in 2024
Health to U is a provider of a digital health and wellbeing platform that emphasizes holistic health, sports, and nutrition. The H2U Digital Health platform is designed to harness the power of data, offering users insightful analyses based on information collected from various connected products and services. This innovative framework allows individuals to access their health records at any time, enabling them to monitor their physiological states effectively. The platform also offers personalized health solutions and products, along with a range of healthcare services, including intelligent health examinations and artificial intelligence health analysis. By integrating these features, Health to U aims to empower users to take control of their health and well-being.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.